Reilley, M., Bailey, A., , Janku, F., Naing, A., Falchook, G., … Hong, D. Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies. Journal for Immunotherapy of Cancer, 5, 35. https://doi.org/10.1186/s40425-017-0238-1 (Original work published 2017)

Adashek, J., Subbiah, I., Matos, I., Garralda, E., Menta, A., Ganeshan, D., & . (2020). Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact? Trends in Cancer, 6(3), 181-191. https://doi.org/10.1016/j.trecan.2020.01.005